Standard
Urokinase receptor forms in serum from non-small cell lung cancer patients : relation to prognosis. / Almasi, Charlotte Elberling; Christensen, Ib Jarle; Høyer-Hansen, Gunilla; Danø, Keld; Pappot, Helle; Dienemann, Hendrik; Muley, Thomas.
I:
Lung Cancer, Bind 74, Nr. 3, 12.2011, s. 510-515.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Almasi, CE, Christensen, IJ, Høyer-Hansen, G, Danø, K
, Pappot, H, Dienemann, H & Muley, T 2011, '
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis',
Lung Cancer, bind 74, nr. 3, s. 510-515.
https://doi.org/10.1016/j.lungcan.2011.05.008APA
Almasi, C. E., Christensen, I. J., Høyer-Hansen, G., Danø, K.
, Pappot, H., Dienemann, H., & Muley, T. (2011).
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis.
Lung Cancer,
74(3), 510-515.
https://doi.org/10.1016/j.lungcan.2011.05.008Vancouver
Almasi CE, Christensen IJ, Høyer-Hansen G, Danø K
, Pappot H, Dienemann H o.a.
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis.
Lung Cancer. 2011 dec.;74(3):510-515.
https://doi.org/10.1016/j.lungcan.2011.05.008Author
Almasi, Charlotte Elberling ; Christensen, Ib Jarle ; Høyer-Hansen, Gunilla ; Danø, Keld ; Pappot, Helle ; Dienemann, Hendrik ; Muley, Thomas. / Urokinase receptor forms in serum from non-small cell lung cancer patients : relation to prognosis. I: Lung Cancer. 2011 ; Bind 74, Nr. 3. s. 510-515.
Bibtex
@article{72a8daa246d74c5682512b5db3acadf3,
title = "Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis",
abstract = "To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.",
keywords = "Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Humans, Immunoassay, Male, Middle Aged, Plasminogen Activators, Prognosis, Urokinase-Type Plasminogen Activator",
author = "Almasi, {Charlotte Elberling} and Christensen, {Ib Jarle} and Gunilla H{\o}yer-Hansen and Keld Dan{\o} and Helle Pappot and Hendrik Dienemann and Thomas Muley",
note = "Copyright {\textcopyright} 2011 Elsevier Ireland Ltd. All rights reserved.",
year = "2011",
month = dec,
doi = "10.1016/j.lungcan.2011.05.008",
language = "English",
volume = "74",
pages = "510--515",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",
}
RIS
TY - JOUR
T1 - Urokinase receptor forms in serum from non-small cell lung cancer patients
T2 - relation to prognosis
AU - Almasi, Charlotte Elberling
AU - Christensen, Ib Jarle
AU - Høyer-Hansen, Gunilla
AU - Danø, Keld
AU - Pappot, Helle
AU - Dienemann, Hendrik
AU - Muley, Thomas
N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
PY - 2011/12
Y1 - 2011/12
N2 - To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.
AB - To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Carcinoma, Non-Small-Cell Lung
KW - Female
KW - Humans
KW - Immunoassay
KW - Male
KW - Middle Aged
KW - Plasminogen Activators
KW - Prognosis
KW - Urokinase-Type Plasminogen Activator
U2 - 10.1016/j.lungcan.2011.05.008
DO - 10.1016/j.lungcan.2011.05.008
M3 - Journal article
C2 - 21640427
VL - 74
SP - 510
EP - 515
JO - Lung Cancer
JF - Lung Cancer
SN - 0169-5002
IS - 3
ER -
